ICU Medical, Inc. (FRA:IC7)
Germany · Delayed Price · Currency is EUR 127.00
-1.00 (-0.78%)
At close: Nov 28, 2025
ICU Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 2,320 | 2,382 | 2,259 | 2,280 | 1,316 | 1,271 | Upgrade |
| 2,320 | 2,382 | 2,259 | 2,280 | 1,316 | 1,271 | Upgrade | |
Revenue Growth (YoY) | -0.84% | 5.44% | -0.92% | 73.21% | 3.56% | 0.38% | Upgrade |
Cost of Revenue | 1,474 | 1,557 | 1,519 | 1,582 | 824.82 | 809.51 | Upgrade |
Gross Profit | 846.31 | 824.78 | 739.87 | 697.76 | 491.49 | 461.5 | Upgrade |
Selling, General & Admin | 628.25 | 638.76 | 606.69 | 608.35 | 302.58 | 283.95 | Upgrade |
Research & Development | 88.76 | 88.62 | 85.34 | 92.98 | 47.5 | 42.95 | Upgrade |
Operating Expenses | 717.01 | 727.38 | 692.04 | 701.33 | 350.08 | 326.9 | Upgrade |
Operating Income | 129.3 | 97.41 | 47.84 | -3.57 | 141.41 | 134.6 | Upgrade |
Interest Expense | -96.75 | -106.54 | -102.73 | -70.81 | -0.86 | -1.75 | Upgrade |
Interest & Investment Income | 10.9 | 10.79 | 7.51 | 4.43 | 2.84 | 3.68 | Upgrade |
Currency Exchange Gain (Loss) | -2.62 | -9.79 | -5.92 | -5.78 | -1.02 | - | Upgrade |
Other Non Operating Income (Expenses) | -2.56 | -4.92 | -2.43 | 3.2 | 0.63 | 2.81 | Upgrade |
EBT Excluding Unusual Items | 39.57 | -13.06 | -55.74 | -72.53 | 143 | 139.33 | Upgrade |
Merger & Restructuring Charges | -55.82 | -59.84 | -41.26 | -71.42 | -18.04 | -28.41 | Upgrade |
Gain (Loss) on Sale of Assets | 41.52 | -1.61 | -0.15 | -2.55 | -1.65 | 1.77 | Upgrade |
Other Unusual Items | 1.41 | 5.4 | 16.25 | 32.09 | -0.13 | -15.2 | Upgrade |
Pretax Income | 29.77 | -66.01 | -78.3 | -114.41 | 123.19 | 97.49 | Upgrade |
Income Tax Expense | 37.14 | 51.68 | -48.64 | -40.12 | 20.05 | 10.62 | Upgrade |
Net Income | -7.36 | -117.69 | -29.66 | -74.29 | 103.14 | 86.87 | Upgrade |
Net Income to Common | -7.36 | -117.69 | -29.66 | -74.29 | 103.14 | 86.87 | Upgrade |
Net Income Growth | - | - | - | - | 18.72% | -14.02% | Upgrade |
Shares Outstanding (Basic) | 25 | 24 | 24 | 24 | 21 | 21 | Upgrade |
Shares Outstanding (Diluted) | 25 | 24 | 24 | 24 | 22 | 22 | Upgrade |
Shares Change (YoY) | 1.20% | 1.23% | 0.93% | 9.58% | 0.88% | 0.21% | Upgrade |
EPS (Basic) | -0.30 | -4.83 | -1.23 | -3.11 | 4.86 | 4.16 | Upgrade |
EPS (Diluted) | -0.31 | -4.83 | -1.23 | -3.11 | 4.74 | 4.02 | Upgrade |
EPS Growth | - | - | - | - | 17.91% | -14.29% | Upgrade |
Free Cash Flow | 71.96 | 124.66 | 82.31 | -152.44 | 199 | 130.75 | Upgrade |
Free Cash Flow Per Share | 2.93 | 5.11 | 3.42 | -6.39 | 9.14 | 6.06 | Upgrade |
Gross Margin | 36.47% | 34.63% | 32.75% | 30.60% | 37.34% | 36.31% | Upgrade |
Operating Margin | 5.57% | 4.09% | 2.12% | -0.16% | 10.74% | 10.59% | Upgrade |
Profit Margin | -0.32% | -4.94% | -1.31% | -3.26% | 7.83% | 6.83% | Upgrade |
Free Cash Flow Margin | 3.10% | 5.23% | 3.64% | -6.69% | 15.12% | 10.29% | Upgrade |
EBITDA | 332.21 | 316.92 | 276.61 | 231.58 | 231.11 | 220.23 | Upgrade |
EBITDA Margin | 14.32% | 13.30% | 12.24% | 10.16% | 17.56% | 17.33% | Upgrade |
D&A For EBITDA | 202.91 | 219.51 | 228.77 | 235.15 | 89.7 | 85.63 | Upgrade |
EBIT | 129.3 | 97.41 | 47.84 | -3.57 | 141.41 | 134.6 | Upgrade |
EBIT Margin | 5.57% | 4.09% | 2.12% | -0.16% | 10.74% | 10.59% | Upgrade |
Effective Tax Rate | 124.73% | - | - | - | 16.28% | 10.90% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.